We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+10.26%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$1.43B
AUM Growth
+$167M
(+13%)
Cap. Flow
+$55.7M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
33.03%
Holding
148
New
41
Increased
26
Reduced
22
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chord Energy
CHRD
|
+$28.8M |
| 2 |
Devon Energy
DVN
|
+$24.8M |
| 3 |
Agilent Technologies
A
|
+$22.5M |
| 4 |
Microsoft
MSFT
|
+$18.9M |
| 5 |
TSG
The Stars Group Inc.
TSG
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$41.1M |
| 2 |
Heron Therapeutics
HRTX
|
+$27.3M |
| 3 |
Applied Materials
AMAT
|
+$23.9M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$23.4M |
| 5 |
Visa
V
|
+$20.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.01% |
| 2 | Technology | 16.97% |
| 3 | Materials | 8.62% |
| 4 | Industrials | 7.83% |
| 5 | Consumer Staples | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Coca-Cola Europacific Partners
CCEP
$47.8B
| $9.78M | 0.68% |
240,570
-593,362
| -71% | -$23.4M |
|
52
Boeing
BA
$185B
| $9.77M | 0.68% |
29,110
-23,717
| -45% | -$8.16M |
|
53
Ashland
ASH
$3.29B
| $9.34M | 0.65% |
+119,511
| New | +$8.9M |
|
54
Global X Uranium ETF
URA
$5.66B
| $9.16M | 0.64% |
+711,906
| New | +$9.6M |
|
|
ARRY
55
DELISTED
Array Biopharma Inc
ARRY
| $9.14M | 0.64% |
544,891
+378,815
| +228% | +$6.03M |
|
56
Thermo Fisher Scientific
TMO
$213B
| $9.06M | 0.63% |
43,740
-29,522
| -40% | -$6.27M |
|
|
GBT
57
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.04M | 0.63% |
+200,000
| New | +$9.11M |
|
|
CARM
58
DELISTED
Carisma Therapeutics
CARM
| $8.67M | 0.6% |
222,278
+161,982
| +269% | +$7.14M |
|
|
GRA
59
DELISTED
W.R. Grace & Co.
GRA
| $8.58M | 0.6% |
+117,017
| New | +$8.21M |
|
|
60
CALL
Heron Therapeutics
HRTX
$96.8M
| $8.41M | 0.59% |
216,600
-183,100
| -46% | -$5.83M |
|
|
PTE
61
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $8.23M | 0.57% |
+13,981
| New | +$8.31M |
|
62
Bunge Global
BG
$20.2B
| $8.17M | 0.57% |
117,195
+109,195
| +1,365% | +$7.82M |
|
|
NEX
63
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $8.11M | 0.57% |
+593,239
| New | +$8.88M |
|
64
WillScot Mobile Mini Holdings
WSC
$4.66B
| $8.08M | 0.56% |
545,952
+270,986
| +99% | +$3.49M |
|
|
CLR
65
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $8.03M | 0.56% |
123,985
-212,952
| -63% | -$13.8M |
|
66
DXC Technology
DXC
$1.78B
| $7.88M | 0.55% |
97,717
-25,765
| -21% | -$2.21M |
|
67
Sea Limited
SE
$68.1B
| $7.64M | 0.53% |
509,188
+499,188
| +4,992% | +$6.41M |
|
68
PUT
Teva Pharmaceuticals
TEVA
$40.2B
| $7.3M | 0.51% |
+300,000
| New | +$6.12M |
|
69
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| $7.1M | 0.5% |
129,942
+34,726
| +36% | +$1.84M |
|
70
CALL
Colgate-Palmolive
CL
$71.9B
| $6.48M | 0.45% |
+100,000
| New | +$6.54M |
|
71
T-Mobile US
TMUS
$190B
| $6.48M | 0.45% |
108,458
-62,566
| -37% | -$3.7M |
|
72
PUT
Pacira BioSciences
PCRX
$1.06B
| $6.27M | 0.44% |
+195,700
| New | +$6.76M |
|
73
Amazon
AMZN
$3.06T
| $6.11M | 0.43% |
+71,900
| New | +$5.71M |
|
|
FSCT
74
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $5.73M | 0.4% |
+167,217
| New | +$5.43M |
|
|
DNR
75
DELISTED
Denbury Resources, Inc.
DNR
| $5.43M | 0.38% |
+1,128,893
| New | +$4.23M |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Kingdon Capital Management held 148 positions worth $1.43B, up 13% from $1.27B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Kingdon Capital Management deployed $55.7M of net new capital in Q2 2018, opening 41 new positions and adding to 26 existing holdings. Its largest new stake was Chord Energy: 2,531,189 shares worth $32.8M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was Heron Therapeutics, an estimated $27.3M trimmed.
- Kingdon Capital Management's largest Q2 2018 buy was Chord Energy: 2,531,189 shares worth $32.8M.
- Kingdon Capital Management added most to Caesars Entertainment Corporation in Q2 2018, an estimated $12.9M increase.
- Kingdon Capital Management's biggest Q2 2018 reduction was Heron Therapeutics, cutting an estimated $27.3M.
- Kingdon Capital Management fully exited Micron Technology in Q2 2018, selling an estimated $41.1M.
- Kingdon Capital Management's ten largest holdings make up 33% of its $1.43B portfolio in Q2 2018.
- Kingdon Capital Management opened 41 new positions and closed 44 in Q2 2018.
- Kingdon Capital Management's portfolio value rose 13% quarter-over-quarter to $1.43B.
Based on Kingdon Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.